Global Nootropics Market to reach USD 6.2 billion by 2027Global Nootropics Market is valued approximately at USD 2.7 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 12.50% over the forecast period 2021-2027. Nootropics are supplements and smart drug or psychological enhancers that are taken in order to enhance cognitive functionality, specifically executive functions, motivation, creativity, and memory, in people with great wellbeing. The Nootropics market is being driven by growing demand in health care sectors, growing awareness regarding Nootropics advantages, antidepressants, energy boosters, and anxiety resistance. Furthermore, the acceptance of nootropics as an enhancement is attracting new market players therefore boosting the market. Moreover, the increased demand from sports industry is also driving the market. Furthermore, the new line of vegan nootropic is also gaining traction. For instance, In April 2019, Gaia Herbs, introduced its first vegan nootropic supplements namely Bacopa, Agile Mind, and Nootropic Focus. However, the high cost of the products, strict regulations framework may hinder the market progress over the forecast period of 2021-2027.

The regional analysis of the Nootropics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is has emerged as a significant region across the world in terms of market share due to favorable government regulations. Moreover, this region exhibits historically great interest in herbal based product which is expected to stimulate product demand in the region. Whereas North America is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027, due to high awareness in consumer population for preventive and cognitive health and increasing number of self-directed consumers in the region.
Major market player included in this report are:
United Pharmacies
AlternaScript LLC
Cephalon, Inc.
Clarity Nootropics
Nootrobox, Inc.
Onnit Labs LLC
Peak Nootropics
Powder City LLC
Purelife Bioscience Co., Ltd
SupNootropic Biological Technology Co. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Distribution Channel:
Offline
Online
By End Use:
Memory Enhancement
Mood & Depression
Sleep & Recovery
Longevity & Anti-aging
Attention & Focus
Anxiety
By Product Type:
Racetams
Ampakines
Choline & Acetylcholine Intermediates
Synthetic B-Vitamin Derived Nootropics
Natural Nootropics
Peptide Nootropics
Smart Drugs


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Nootropics (PSF) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors